% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{PfeiferSerrahima:212443,
author = {J. Pfeifer Serrahima and C. Zhang$^*$ and P. Oberoi$^*$ and
M. Bodden and J. Röder and C. Arndt and A. Feldmann and A.
Kiefer and M. Prüfer and I. Kühnel and T. Tonn$^*$ and M.
Bachmann$^*$ and W. S. Wels$^*$},
title = {{M}ultivalent adaptor proteins specifically target {NK}
cells carrying a universal chimeric antigen receptor to
{E}rb{B}2 ({HER}2)-expressing cancers.},
journal = {Cancer immunology immunotherapy},
volume = {72},
number = {9},
issn = {0340-7004},
address = {Heidelberg},
publisher = {Springer},
reportid = {DKFZ-2023-00162},
pages = {2905-2918},
year = {2023},
note = {2023 Sep;72(9):2905-2918},
abstract = {Chimeric antigen receptor (CAR)-engineered immune effector
cells constitute a promising approach for adoptive cancer
immunotherapy. Nevertheless, on-target/off-tumor toxicity
and immune escape due to antigen loss represent considerable
challenges. These may be overcome by adaptor CARs that are
selectively triggered by bispecific molecules that crosslink
the CAR with a tumor-associated surface antigen. Here, we
generated NK cells carrying a first- or second-generation
universal CAR (UniCAR) and redirected them to tumor cells
with so-called target modules (TMs) which harbor an ErbB2
(HER2)-specific antibody domain for target cell binding and
the E5B9 peptide recognized by the UniCAR. To investigate
differential effects of the protein design on activity, we
developed homodimeric TMs with one, two or three E5B9
peptides per monomer, and binding domains either directly
linked or separated by an IgG4 Fc domain. The adaptor
molecules were expressed as secreted proteins in Expi293F
cells, purified from culture supernatants and their
bispecific binding to UniCAR and ErbB2 was confirmed by flow
cytometry. In cell killing experiments, all tested TMs
redirected NK cell cytotoxicity selectively to
ErbB2-positive tumor cells. Nevertheless, we found
considerable differences in the extent of specific cell
killing depending on TM design and CAR composition, with
adaptor proteins carrying two or three E5B9 epitopes being
more effective when combined with NK cells expressing the
first-generation UniCAR, while the second-generation UniCAR
was more active in the presence of TMs with one E5B9
sequence. These results may have important implications for
the further development of optimized UniCAR and target
module combinations for cancer immunotherapy.},
keywords = {Chimeric antigen receptor (Other) / ErbB2 (Other) / HER2
(Other) / NK-92 (Other) / Natural killer cells (Other) /
UniCAR (Other)},
cin = {FM01 / DD01},
ddc = {610},
cid = {I:(DE-He78)FM01-20160331 / I:(DE-He78)DD01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36688995},
doi = {10.1007/s00262-023-03374-x},
url = {https://inrepo02.dkfz.de/record/212443},
}